Information on research, events, activities, and news from the T1D community across Canada.
Now that 2019 has drawn to a close, we want to take a moment and extend our sincere thanks and appreciation for your support of our efforts in finding cures for type 1 diabetes (T1D) and improving the lives of the more than 300,000 Canadians and their families touched by this disease.
We’re so happy to share our 8 finalists with you – meet our 2020 Manitoba Lobby Day Delegates!
She was the youngest person in the room, and her presentation was met with resounding applause from the entire audience. Fourteen-year old Anne Pettigrew made an impressive and compelling presentation at last month’s Ontario pre-budget consultations in Scarborough.
Drs. Ahmad Haidar, Laurent Legault, Michael Tsoukas and Jean-Franҫois Yale are a team of JDRF-funded researchers at McGill University (Montreal) who are the first to test the addition of pramlintide (a synthetic form of amylin, which is a hormone co-secreted with insulin by the healthy pancreas) to ...
I have been blown away by the strength, resilience and generosity demonstrated by you, our JDRF family. I am reminded of how privileged we are to have your continued support.
We are sharing information that addresses some of the top concerns of the T1D community. Note these responses are not intended to be medical advice, for that—as always—you must consult your own healthcare team.
Knowing that many research institutes are closed or have temporarily diverted staff or resources to the COVID-19 pandemic, we are now asking the question: What does this mean for T1D research?
If you haven’t yet heard, you’ve been invited to Canada’s largest virtual house party turning type one diabetes into type none…the JDRF House ParT1D for a Cure, presented by Omnipod!
Dr. Pepper is a promising young Canadian scientist and a new assistant professor in the Department of Surgery at the University of Alberta.
JDRF’s message to the government was straightforward and simple: Manitobans with type 1 diabetes at all ages need access to insulin pumps.